Picton Mahoney Asset Management Amphastar Pharmaceuticals, Inc. Transaction History
Picton Mahoney Asset Management
- $9.71 Billion
- Q2 2025
A detailed history of Picton Mahoney Asset Management transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 24 shares of AMPH stock, worth $569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 1,608
98.51%
Holding current value
$569
Previous $46,000
97.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
261Shares Held
32.9MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...